Pregnancy in women with heart disease. risk assessment and management of heart failure.

Heart Failure Clinics

Volumn 10, Issue 1, 2014, Pages 117-129

  Grewal, Jasmine ^a   Silversides, Candice K ^b,c   Colman, Jack M ^b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cardiomyopathy; Congenital heart disease; Heart failure; Pregnancy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIVITAMIN K; ATENOLOL; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ENALAPRIL; EPLERENONE; ESTROGEN; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; MILRINONE; NESIRITIDE; NITRATE; NITROPRUSSIDE SODIUM; OXYTOCIN; PEPTIDE; RENIN INHIBITOR; SPIRONOLACTONE; VASODILATOR AGENT;

ACUTE HEART FAILURE; ANEMIA; ANTICOAGULATION; AORTA STENOSIS; BICUSPID AORTIC VALVE; CARDIOVASCULAR MAGNETIC RESONANCE; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; DIASTOLIC BLOOD PRESSURE; DIURETIC THERAPY; DYSPNEA; ECHOCARDIOGRAPHY; EISENMENGER COMPLEX; ELECTROCARDIOGRAM; EPIDURAL ANESTHESIA; EXERCISE TEST; EXERCISE TOLERANCE; FALLOT TETRALOGY; FATIGUE; FETUS DISEASE; FIRST TRIMESTER PREGNANCY; FONTAN PROCEDURE; FOOT EDEMA; GREAT VESSELS TRANSPOSITION; HEART AFTERLOAD; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART OUTPUT; HEART RIGHT LEFT SHUNT; HEART STROKE VOLUME; HUMAN; HYPERTHYROIDISM; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; HYPOVOLEMIA; IONIZING RADIATION; IRON DEFICIENCY; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LOW BIRTH WEIGHT; LUNG CONGESTION; MATERNAL MORTALITY; MEAN ARTERIAL PRESSURE; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTETRIC ANESTHESIA; PERIPARTUM CARDIOMYOPATHY; PHYSICAL ACTIVITY; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL CARE; PULMONARY ARTERY CATHETER; PULMONARY HYPERTENSION; PULMONARY VALVE ATRESIA; PULMONARY VALVE INSUFFICIENCY; REVIEW; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC HEART MURMUR; TACHYCARDIA; TACHYCARDIA INDUCED CARDIOMYOPATHY; TACHYPNEA; THIRD TRIMESTER PREGNANCY; THROMBOEMBOLISM;

CARDIOMYOPATHY; CONGENITAL HEART DISEASE; HEART FAILURE; PREGNANCY;

DISEASE MANAGEMENT; FEMALE; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL CARE; RISK ASSESSMENT; RISK FACTORS;

EID: 84888036755     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2013.09.014     Document Type: Review

References (70)

1. de Swiet M. Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom. Am J Obstet Gynecol 2000, 182(4):760-766.
2. Stevenson J.C., Macdonald D.W., Warren R.C., et al. Increased concentration of circulating calcitonin gene related peptide during normal human pregnancy. Br Med J (Clin Res Ed) 1986, 293(6558):1329-1330.
3. Williams D.J., Vallance P.J., Neild G.H., et al. Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol 1997, 272(2 Pt 2):H748-H752.
4. Easterling T.R., Benedetti T.J., Schmucker B.C., et al. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 1990, 76(6):1061-1069.
5. Pritchard J.A. Changes in the blood volume during pregnancy and delivery. Anesthesiology 1965, 26:393-399.
6. Hunter S., Robson S.C. Adaptation of the maternal heart in pregnancy. Br Heart J 1992, 68(6):540-543.
7. Gilson G.J., Mosher M.D., Conrad K.P. Systemic hemodynamics and oxygen transport during pregnancy in chronically instrumented, conscious rats. Am J Physiol 1992, 263(6 Pt 2):H1911-H1918.
8. Gilson G.J., Samaan S., Crawford M.H., et al. Changes in hemodynamics, ventricular remodeling, and ventricular contractility during normal pregnancy: a longitudinal study. Obstet Gynecol 1997, 89(6):957-962.
9. Hennessy T.G., MacDonald D., Hennessy M.S., et al. Serial changes in cardiac output during normal pregnancy: a Doppler ultrasound study. Eur J Obstet Gynecol Reprod Biol 1996, 70(2):117-122.
10. Karamermer Y., Roos-Hesselink J.W. Pregnancy and adult congenital heart disease. Expert Rev Cardiovasc Ther 2007, 5(5):859-869.
11. Robson S.C., Hunter S., Boys R.J., et al. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989, 256(4 Pt 2):H1060-H1065.
12. Hendricks C.H., Quilligan E.J. Cardiac output during labor. Am J Obstet Gynecol 1956, 71(5):953-972.
13. Robson S.C., Hunter S., Moore M., et al. Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol 1987, 94(11):1028-1039.
14. Khairy P., Ouyang D.W., Fernandes S.M., et al. Pregnancy outcomes in women with congenital heart disease. Circulation 2006, 113(4):517-524.
15. Siu S.C., Sermer M., Colman J.M., et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001, 104(5):515-521.
16. Siu S.C., Sermer M., Harrison D.A., et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997, 96(9):2789-2794.
17. Drenthen W., Boersma E., Balci A., et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010, 31(17):2124-2132.
18. Jessup M., Abraham W.T., Casey D.E., et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: areport of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119(14):1977-2016.
19. McKelvie R.S., Moe G.W., Ezekowitz J.A., et al. The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol 2013, 29(2):168-181.
20. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. NEngl J Med 2006, 354(23):2443-2451.
21. Schaefer C. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. Birth Defects Res A Clin Mol Teratol 2003, 67(8):591-594.
22. Lydakis C., Lip G.Y., Beevers M., et al. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999, 12(6):541-547.
23. Regitz-Zagrosek V., Blomstrom Lundqvist C., Borghi C., et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011, 32(24):3147-3197.
24. Sliwa K., Fett J., Elkayam U. Peripartum cardiomyopathy. Lancet 2006, 368(9536):687-693.
25. Mirshahi M., Ayani E., Nicolas C., et al. The blockade of mineralocorticoid hormone signaling provokes dramatic teratogenesis in cultured rat embryos. Int J Toxicol 2002, 21(3):191-199.
26. Robertson J.E., Silversides C.K., Mah M.L., et al. Acontemporary approach to the obstetric management of women with heart disease. JObstet Gynaecol Can 2012, 34(9):812-819.
27. Goldszmidt E., Macarthur A., Silversides C., et al. Anesthetic management of a consecutive cohort of women with heart disease for labor and delivery. Int J Obstet Anesth 2010, 19(3):266-272.
28. Beardmore K.S., Morris J.M., Gallery E.D. Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens Pregnancy 2002, 21(1):85-95.
29. Drenthen W., Pieper P.G., Roos-Hesselink J.W., et al. Outcome of pregnancy in women with congenital heart disease: a literature review. JAm Coll Cardiol 2007, 49(24):2303-2311.
30. Opotowsky A.R., Siddiqi O.K., D'Souza B., et al. Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart 2012, 98(2):145-151.
31. Grewal J., Siu S.C., Ross H.J., et al. Pregnancy outcomes in women with dilated cardiomyopathy. JAm Coll Cardiol 2009, 55(1):45-52.
32. Pearson G.D., Veille J.C., Rahimtoola S., et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000, 283(9):1183-1188.
33. Elkayam U., Akhter M.W., Singh H., et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early andlate presentation. Circulation 2005, 111(16):2050-2055.
34. Habli M., O'Brien T., Nowack E., et al. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol 2008, 199(4):415.e1-415.e5.
35. Dos L., Teruel L., Ferreira I.J., et al. Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart 2005, 91(5):652-656.
36. Graham T.P., Bernard Y.D., Mellen B.G., et al. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. JAm Coll Cardiol 2000, 36(1):255-261.
37. Drenthen W., Pieper P.G., Ploeg M., et al. Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries. Eur Heart J 2005, 26(23):2588-2595.
38. Canobbio M.M., Morris C.D., Graham T.P., et al. Pregnancy outcomes after atrial repair for transpositionof the great arteries. Am J Cardiol 2006, 98(5):668-672.
39. Connolly H.M., Grogan M., Warnes C.A. Pregnancy among women with congenitally corrected transposition of great arteries. JAm Coll Cardiol 1999, 33(6):1692-1695.
40. Therrien J., Barnes I., Somerville J. Outcome of pregnancy in patients with congenitally corrected transposition of the great arteries. Am J Cardiol 1999, 84(7):820-824.
41. Guedes A., Mercier L.A., Leduc L., et al. Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries. JAm Coll Cardiol 2004, 44(2):433-437.
42. Bowater S.E., Selman T.J., Hudsmith L.E., et al. Long-term outcome following pregnancy in women with a systemic right ventricle: is the deterioration due to pregnancy or a consequence of time?. Congenit Heart Dis 2013, 8(4):302-307.
43. Balci A., Drenthen W., Mulder B.J., et al. Pregnancy inwomen with corrected tetralogy of Fallot: occurrence and predictors of adverse events. Am Heart J 2011, 161(2):307-313.
44. Veldtman G.R., Connolly H.M., Grogan M., et al. Outcomes of pregnancy in women with tetralogy of Fallot. JAm Coll Cardiol 2004, 44(1):174-180.
45. Egidy Assenza G., Cassater D., Landzberg M., et al. The effects of pregnancy on right ventricular remodeling in women with repaired tetralogy of Fallot. Int J Cardiol 2013, 168(3):1847-1852.
46. Le Gloan L., Mercier L.A., Dore A., et al. Pregnancy in women with Fontan physiology. Expert Rev Cardiovasc Ther 2011, 9(12):1547-1556.
47. Drenthen W., Pieper P.G., Roos-Hesselink J.W., et al. Pregnancy and delivery in women after Fontan palliation. Heart 2006, 92(9):1290-1294.
48. Canobbio M.M., Mair D.D., van der Velde M., et al. Pregnancy outcomes after the Fontan repair. JAm Coll Cardiol 1996, 28(3):763-767.
49. Presbitero P., Somerville J., Stone S., et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 1994, 89(6):2673-2676.
50. Weiss B.M., Zemp L., Seifert B., et al. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. JAm Coll Cardiol 1998, 31(7):1650-1657.
51. Balint O.H., Siu S.C., Mason J., et al. Cardiac outcomes after pregnancy in women with congenital heart disease. Heart 2010, 96(20):1656-1661.
52. Lesniak-Sobelga A., Tracz W., KostKiewicz M., et al. Clinical and echocardiographic assessment of pregnant women with valvular heart diseases-maternal and fetal outcome. Int J Cardiol 2004, 94(1):15-23.
53. Hameed A., Karaalp I.S., Tummala P.P., et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. JAm Coll Cardiol 2001, 37(3):893-899.
54. Silversides C.K., Colman J.M., Sermer M., et al. Early and intermediate-term outcomes of pregnancy withcongenital aortic stenosis. Am J Cardiol 2003, 91(11):1386-1389.
55. Yap S.C., Drenthen W., Pieper P.G., et al. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol 2008, 126(2):240-246.
56. Tzemos N., Silversides C.K., Colman J.M., et al. Late cardiac outcomes after pregnancy in women withcongenital aortic stenosis. Am Heart J 2009, 157(3):474-480.
57. Barth W.H. Cardiac surgery in pregnancy. Clin Obstet Gynecol 2009, 52(4):630-646.
58. Silversides C.K., Colman J.M., Sermer M., et al. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 2003, 91(11):1382-1385.
59. Elkayam U., Bitar F. Valvular heart disease and pregnancy part I: native valves. JAm Coll Cardiol 2005, 46(2):223-230.
60. Gowda R.M., Khan I.A., Mehta N.J., et al. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol 2003, 88(2-3):129-133.
61. Lui G.K., Silversides C.K., Khairy P., et al. Heart rate response during exercise and pregnancy outcome in women with congenital heart disease. Circulation 2011, 123(3):242-248.
62. Campos O., Andrade J.L., Bocanegra J., et al. Physiologic multivalvular regurgitation during pregnancy: a longitudinal Doppler echocardiographic study. Int J Cardiol 1993, 40(3):265-272.
63. Okuda Y., Sagami F., Tirone P., et al. Reproductive anddevelopmental toxicity study of gadobenate dimeglumine formulation (E7155) (3)-study of embryo-fetal toxicity in rabbits by intravenous administration. JToxicol Sci 1999, 24(Suppl 1):79-87.
64. Tanous D., Siu S.C., Mason J., et al. B-type natriuretic peptide in pregnant women with heart disease. JAm Coll Cardiol 2010, 56(15):1247-1253.
65. Sliwa K., Hilfiker-Kleiner D., Petrie M.C., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010, 12(8):767-778.
66. Sliwa K., Forster O., Libhaber E., et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006, 27(4):441-446.
67. Lampert M.B., Weinert L., Hibbard J., et al. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol 1997, 176(1 Pt 1):189-195.
68. Autore C., Conte M.R., Piccininno M., et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. JAm Coll Cardiol 2002, 40(10):1864-1869.
69. Thaman R., Varnava A., Hamid M.S., et al. Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart 2003, 89(7):752-756.
70. Spirito P., Autore C. Management of hypertrophic cardiomyopathy. BMJ 2006, 332(7552):1251-1255.